Laminopathies

• EMA approval · 2026-04-07
  EMA Authorised: Zokinvy (Lonafarnib) — TMC Pharma (EU) Limited

  The European Medicines Agency authorised Zokinvy (lonafarnib) for Hutchinson-Gilford progeria syndrome and laminopathies in the European Uni…

• CLINICAL_TRIALS research · 2026-03-04
  Clinical Trial Update: Modifying Factors in Striated Muscle Laminopathies [NA]

  This clinical trial is currently recruiting to study factors that modify disease presentation in laminopathies affecting striated muscle.

• CLINICAL_TRIALS research · 2025-03-13
  Clinical Trial Update: Observatoire Des Patients Atteints de Laminopathies et Emerinopathies (Observatory for PAtients With Laminopathies and Emerinopathies)

  An observational clinical trial registry sponsored by Pitié-Salpêtrière Hospital for patients with laminopathies and emerinoopathies, curren…

• CLINICAL_TRIALS research · 2025-02-07
  Clinical Trial Update: Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

  This clinical trial update describes a study at IRCCS Azienda Ospedaliero-Universitaria di Bologna that aims to characterize patients with v…

• CLINICAL_TRIALS research · 2016-04-06
  Clinical Trial Update: Cardiac Arrhythmias and Sudden Death in Patients Affected With Laminopathies [NA]

  This clinical trial update describes an ongoing study (NCT02601066) examining cardiac arrhythmias and sudden death in patients with laminopa…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.